EUVIMEDEUVIMED entdecken
Crossref

Phala Ghrita in Ovulatory Infertility: An Integrative Review of Ayurvedic Concepts, Pharmacology, and Biomedical Evidence.

Mohan Yende, Dandekar Pradnya, Gaurav Sawarkar, Thosar Sheetal, Tawalare Kalpana

International Journal of Drug Delivery Technology · 29.05.2026 · 16 (34s)

DOI: 10.25258/ijddt.16.34s.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 29.05.2026. Verfasst von Mohan Yende und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Female infertility remains a major global health challenge, with ovulatory disorders accounting for nearly one-third of cases. Conventional ovulation induction therapies, particularly clomiphene citrate, though effective, are often associated with limitations such as anti-estrogenic endometrial effects, drug resistance, adverse events, and high costs, prompting the need for safer and holistic alternatives. Ayurveda conceptualizes infertility (Vandhyatva) as a multifactorial disorder involving impairment of Beeja (gametes), Ritu (fertile period), Kshetra (reproductive organs), and Ambu (nutrition), with Beejotsarga (ovulation) being a pivotal event for conception. Phala Ghrita, a classical polyherbal ghee-based formulation described in authoritative Ayurvedic texts, has long been used in the management of female infertility and gynecological disorders. This narrative review integrates classical Ayurvedic concepts with contemporary biomedical evidence to elucidate the potential role of Phala Ghrita in folliculogenesis and ovulation. Classical pharmacological attributes, formulation composition, physicochemical standardization, and proposed mechanisms of action are critically examined. Preclinical evidence from rodent models demonstrates that Phala Ghrita improves estrous cyclicity, ovarian follicular architecture, hormonal balance, antioxidant status, and endometrial receptivity. Emerging molecular insights further suggest its role in optimizing the follicular microenvironment through antioxidant protection of oocyte mitochondria and modulation of oocyte–granulosa cell signalling pathways. Clinical studies, though limited in scale, indicate favorable safety and encouraging trends in improving fertility-related outcomes. When compared with clomiphene citrate, Phala Ghrita appears to exert a gentler, restorative action on the hypothalamic–pituitary–ovarian axis without compromising endometrial receptivity. Overall, Phala Ghrita represents a promising integrative therapeutic option for ovulatory infertility. However, well-designed, large-scale randomized controlled trials focusing on ovulationspecific endpoints are warranted to validate its clinical efficacy and mechanistic pathways.

Zitieren

APA

Yende, M., Pradnya, D., Sawarkar, G., Sheetal, T., & Kalpana, T. (2026). Phala Ghrita in Ovulatory Infertility: An Integrative Review of Ayurvedic Concepts, Pharmacology, and Biomedical Evidence. International Journal of Drug Delivery Technology, 16(34s). https://doi.org/10.25258/ijddt.16.34s.16

Vancouver

Yende M, Pradnya D, Sawarkar G, Sheetal T, Kalpana T. Phala Ghrita in Ovulatory Infertility: An Integrative Review of Ayurvedic Concepts, Pharmacology, and Biomedical Evidence. International Journal of Drug Delivery Technology. 2026;16(34s). doi:10.25258/ijddt.16.34s.16

BibTeX
@article{Yende2026,
  author = {Yende, Mohan and Pradnya, Dandekar and Sawarkar, Gaurav and Sheetal, Thosar and Kalpana, Tawalare},
  title = {Phala Ghrita in Ovulatory Infertility: An Integrative Review of Ayurvedic Concepts, Pharmacology, and Biomedical Evidence},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {34s},
  doi = {10.25258/ijddt.16.34s.16}
}
Kostenlos starten →